• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

儿童白消安肺

Busulphan lung in childhood.

作者信息

Oakhill A, Green I D, Knowlson G T, Cameron A H, Shah K J, Hill F G, Mann J R

出版信息

J Clin Pathol. 1981 May;34(5):495-500. doi: 10.1136/jcp.34.5.495.

DOI:10.1136/jcp.34.5.495
PMID:6941971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC493331/
Abstract

A child receiving busulphan treatment for adult-type chronic myeloid leukaemia responded well for four years before the onset of complications leading to "busulphan lung'. Pulmonary function tests (PFT) were useful in monitoring the development of this condition and we recommended regular PFT for patient receiving busulphan treatment.

摘要

一名接受白消安治疗成人型慢性粒细胞白血病的儿童在出现导致“白消安肺”的并发症之前，病情良好地缓解了四年。肺功能测试（PFT）有助于监测这种情况的发展，我们建议对接受白消安治疗的患者定期进行肺功能测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/97b393461fbf/jclinpath00486-0044-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/434c643c46c7/jclinpath00486-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/6e932d6b66a4/jclinpath00486-0042-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/0bdbfc1f07f5/jclinpath00486-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/809c656a730d/jclinpath00486-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/97b393461fbf/jclinpath00486-0044-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/434c643c46c7/jclinpath00486-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/6e932d6b66a4/jclinpath00486-0042-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/0bdbfc1f07f5/jclinpath00486-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/809c656a730d/jclinpath00486-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b84/493331/97b393461fbf/jclinpath00486-0044-a.jpg

相似文献

1
Busulphan lung in childhood.儿童白消安肺
J Clin Pathol. 1981 May;34(5):495-500. doi: 10.1136/jcp.34.5.495.
2
Busulphan lung.白消安肺
Thorax. 1969 Nov;24(6):639-55. doi: 10.1136/thx.24.6.639.
3
Busulphan lung.白消安肺
Med J Aust. 1972 Sep 23;2(13):719-22. doi: 10.5694/j.1326-5377.1972.tb103507.x.
4
Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
Scand J Respir Dis. 1972;53(5):265-73.
5
Busulphan lung: electron microscopy.白消安肺：电子显微镜检查
Thorax. 1970 Mar;25(2):257. doi: 10.1136/thx.25.2.257-c.
6
Lung function in patients receiving busulphan.接受白消安治疗的患者的肺功能。
Br Med J. 1970 Nov 28;4(5734):530-2. doi: 10.1136/bmj.4.5734.530.
7
[Busulfan lung. Pulmonary fibrosis caused by Myleran].
Med Welt. 1976 Feb 13;27(7):308-11.
8
Busulfan lung. Report of two cases and review of the literature.
Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):151-6. doi: 10.2214/ajr.120.1.151.
9
Busulfan lung.白消安肺病变
Am J Dis Child. 1977 Jun;131(6):650-2.
10
Busulphan lung: histopathology.白消安肺：组织病理学
Thorax. 1970 Mar;25(2):257. doi: 10.1136/thx.25.2.257-b.

引用本文的文献

1
Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.小儿肿瘤患者中白消安诱导的肺损伤——文献综述及病例说明
Pediatr Allergy Immunol Pulmonol. 2019 Sep 1;32(3):86-91. doi: 10.1089/ped.2019.0990. Epub 2019 Sep 17.
2
Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient.一名自体干细胞移植受者发生肝窦阻塞综合征及白消安诱导的肺损伤
Indian Pediatr. 2017 Sep 15;54(9):765-770. doi: 10.1007/s13312-017-1172-5.
3
Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).

本文引用的文献

1
DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY.白消安治疗后弥漫性间质性肺纤维化
Lancet. 1963 Aug 31;2(7305):432-4. doi: 10.1016/s0140-6736(63)92173-1.
2
Interstitial pulmonary fibrosis following busulfan therapy.白消安治疗后发生的间质性肺纤维化。
Am J Med. 1961 Jul;31:134-9. doi: 10.1016/0002-9343(61)90229-7.
3
Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Cancer. 1971 May;27(5):1074-80. doi: 10.1002/1097-0142(197105)27:5<1074::aid-cncr2820270511>3.0.co;2-g.
儿童癌症治疗后的肺功能。圣裘德终身队列研究（SJLIFE）报告。
Ann Am Thorac Soc. 2016 Sep;13(9):1575-85. doi: 10.1513/AnnalsATS.201601-022OC.
4
Systemic histopathology of infant rats exposed to busulfan.暴露于白消安的幼鼠的全身组织病理学
J Toxicol Pathol. 2014 Apr;27(1):25-9. doi: 10.1293/tox.2013-0043. Epub 2014 Apr 30.
4
Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Am Rev Respir Dis. 1970 Mar;101(3):408-13. doi: 10.1164/arrd.1970.101.3.408.
5
Busulphan lung.白消安肺
Thorax. 1969 Nov;24(6):639-55. doi: 10.1136/thx.24.6.639.
6
Busulphan lung.白消安肺
Thorax. 1968 Mar;23(2):187-93. doi: 10.1136/thx.23.2.187.
7
Two cases of busulfan toxicity.两例白消安毒性病例。
Ann Intern Med. 1966 Jan;64(1):154-64. doi: 10.7326/0003-4819-64-1-154.
8
Pulmonary fibrosis following therapy with Melphalan for multiple myeloma.美法仑治疗多发性骨髓瘤后发生的肺纤维化。
J Clin Pathol. 1972 Aug;25(8):668-73. doi: 10.1136/jcp.25.8.668.
9
Interstitial pneumonia after prolonged treatment with cyclophosphamide.环磷酰胺长期治疗后出现的间质性肺炎。
Am Rev Respir Dis. 1973 Jul;108(1):114-7. doi: 10.1164/arrd.1973.108.1.114.
10
Busulphan lung.白消安肺
Med J Aust. 1972 Sep 23;2(13):719-22. doi: 10.5694/j.1326-5377.1972.tb103507.x.